De vertaling van deze pagina is experimenteel en in ontwikkeling. Uw is welkom!
USANA Health Sciences Balans Gezondheid
Financiële gezondheid criteriumcontroles 6/6
USANA Health Sciences heeft een totaal eigen vermogen van $512.2M en een totale schuld van $0.0, wat de schuld-eigenvermogensverhouding op 0% brengt. De totale activa en totale passiva bedragen respectievelijk $631.4M en $119.2M. De EBIT USANA Health Sciences is $84.3M waardoor de rentedekking -7.8 is. Het heeft contanten en kortetermijnbeleggingen van $332.4M.
Belangrijke informatie
0%
Verhouding schuld/eigen vermogen
US$0
Schuld
| Rente dekkingsratio | -7.8x |
| Contant | US$332.42m |
| Aandelen | US$512.21m |
| Totaal verplichtingen | US$119.21m |
| Totaal activa | US$631.42m |
Recente financiële gezondheidsupdates
Recent updates
USANA Health Sciences (NYSE:USNA) Could Be Struggling To Allocate Capital
Sep 26
Is There Now An Opportunity In USANA Health Sciences, Inc. (NYSE:USNA)?
Sep 08USANA Health Sciences, Inc. Earnings Missed Analyst Estimates: Here's What Analysts Are Forecasting Now
Jul 26There Is A Reason USANA Health Sciences, Inc.'s (NYSE:USNA) Price Is Undemanding
Jul 17USANA Health Sciences (NYSE:USNA) Might Be Having Difficulty Using Its Capital Effectively
May 29USANA Health Sciences, Inc. Just Beat Analyst Forecasts, And Analysts Have Been Updating Their Predictions
May 03Is Now The Time To Look At Buying USANA Health Sciences, Inc. (NYSE:USNA)?
May 01USANA Health Sciences, Inc.'s (NYSE:USNA) Prospects Need A Boost To Lift Shares
Apr 04USANA Health Sciences (NYSE:USNA) Could Be Struggling To Allocate Capital
Feb 08Is It Too Late To Consider Buying USANA Health Sciences, Inc. (NYSE:USNA)?
Jan 06USANA: New Digital Tools And Solid Balance Sheet Imply Undervaluation
Oct 23Are Investors Undervaluing USANA Health Sciences, Inc. (NYSE:USNA) By 22%?
Sep 09Here's What's Concerning About USANA Health Sciences' (NYSE:USNA) Returns On Capital
Jul 27USANA Earnings Preview: From China's Challenge To India's Promise
Jul 21USANA Health Sciences says Brown will transition to CEO in July 2023
Feb 13Returns On Capital At USANA Health Sciences (NYSE:USNA) Paint A Concerning Picture
Feb 02USANA Health Sciences down 17% after revising 2022 outlook below consensus estimates
Oct 25Here's What To Make Of USANA Health Sciences' (NYSE:USNA) Decelerating Rates Of Return
Oct 18Are Investors Undervaluing USANA Health Sciences, Inc. (NYSE:USNA) By 26%?
Jul 22Returns On Capital At USANA Health Sciences (NYSE:USNA) Have Stalled
Jul 07Is USANA Health Sciences (NYSE:USNA) Using Too Much Debt?
Jun 14Is USANA Health Sciences, Inc. (NYSE:USNA) Potentially Undervalued?
May 31USANA: Soft Quarter, Bottomed Out Stock, 9.8x Ex-Cash P/E, 65% Upside
Apr 28Analyse van de financiële positie
Kortlopende schulden: De korte termijn activa ( $419.1M ) USNA } overtreffen de korte termijn passiva ( $103.9M ).
Langlopende schulden: De kortetermijnactiva USNA ( $419.1M ) overtreffen de langetermijnschulden ( $15.3M ).
Schuld/ eigen vermogen geschiedenis en analyse
Schuldniveau: USNA is schuldenvrij.
Schuld verminderen: USNA had 5 jaar geleden geen schulden.
Schuldendekking: USNA heeft geen schulden en hoeft daarom niet gedekt te worden door de operationele kasstroom.
Rentedekking: USNA heeft geen schulden, dus de dekking van rentebetalingen is geen probleem.